Induction of infectious tolerance by ex vivo reprogrammed immune cells
AssigneeCreative Medical Technologies, Inc.
InventorsThomas Ichim, Amit Patel
Life of this patent
Estimating the term…
Loading patent…
AssigneeCreative Medical Technologies, Inc.
InventorsThomas Ichim, Amit Patel
Estimating the term…
Disclosed are means, methods and compositions of matter useful for inhibiting, in an antigen-specific manner, immunity towards an autoantigen or alloantigen. In one embodiment of the invention, regenerative cells are cultured ex vivo together with immune cells from a mammal suffering from an autoimmune condition. Autoantigens or alloantigens are added in the culture of regenerative cells and cells from an autoimmune disease suffering individual in a manner so that said regenerative cells can endow onto said immune cells of said patient suffering from autoimmunity a state of antigen specific infectious tolerance. In one embodiment, said infectious tolerance involves T regulatory cells inducing conversion of dendritic cells to tolerogeneic dendritic cells, and furthermore in other embodiments administration of tolerogenic dendritic cells induces T regulatory cells.
A method of treating autoimmunity or alloreactivity in a patient comprising the steps of:
Dependencies are inferred from the claim text.